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Although Sox1, Sox2, and Sox3 are all part of the Sox-B1 group of transcriptional regulators, only Sox1 appears to play a direct role in
neural cell fate determination and differentiation. We find that overexpression of Sox1 but not Sox2 or Sox3 in cultured neural progenitor
cells is sufficient to induce neuronal lineage commitment. Sox1 binds directly to the Hes1 promoter and suppresses Hes1 transcription, thus
attenuating Notch signaling. Sox1 also binds to h-catenin and suppresses h-catenin-mediated TCF/LEF signaling, thus potentially attenuating
the wnt signaling pathway. The C-terminus of Sox1 is required for both of these interactions. Sox1 also promotes exit of cells from cell cycle
and up-regulates transcription of the proneural bHLH transcription factor neurogenin1 (ngn1). These observations suggest that Sox1 works
through multiple independent pathways to promote neuronal cell fate determination and differentiation.
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Sox domain proteins are a class of developmentally
important transcriptional regulators related to the mamma-
lian testis determining factor SRY (Bowles et al., 2000). The
20 Sox genes that have been identified in the mammalian
genome are divided into eight different groups (A through
H) according to sequence similarities (Schepers et al.,
2002). Group B Sox genes are most closely related to
SRY, sharing over 85% sequence identity between their
DNA binding domains (Collignon et al., 1996; Harley et al.,
1994). The SoxB1 gene subfamily including Sox1, Sox2,
and Sox3 has been evolutionarily conserved (Bowles et al.,
2000). The Drosophila (Buescher et al., 2002; Cremazy et
al., 2000; Overton et al., 2002), Xenopus (Mizuseki et al.,
1998a,b), and avian (Rex et al., 1997; Uwanogho et al.,
1995) putative orthologues of Sox1, Sox2, and Sox3 all0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2004.02.005
* Corresponding author. Department of Neurology, Northwestern
University’s Feinberg School of Medicine, Ward Building 10-185, 303
East Chicago Avenue, Chicago, IL 60611-3008. Fax: +1-312-503-0872.
E-mail address: l-kan@northwestern.edu (L. Kan).show expression throughout the neural primordium. Several
lines of evidence suggest that Sox-B1 factors play a role in
neural cell fate determination and differentiation. Mutation
of the Drosophila Sox-B1 proteins, SoxNeuro, and Dichaete
leads to defects in the specification and differentiation of
midline and lateral neural cells, and SoxNeuro or Dichaete
double mutants have severe hypoplasia of the entire central
nervous system (Buescher et al., 2002; Overton et al., 2002).
Xenopus Sox2 can synergize with FGF signaling to initiate
neural differentiation, and injection of a dominant interfer-
ing form of Sox2 mRNA inhibits neural differentiation of
animal caps (Mizuseki et al., 1998a). In fact, a Sox2-hGeo
insertion construct has been used to select neural precursors
from stem cell populations, suggesting that Sox2 is a marker
for early neural fate (Li et al., 1998).
In the mouse, the differing expression profiles of Sox1,
Sox2, and Sox3 during embryogenesis suggest that these
genes may function differently in the control of neural cell
fate. Sox2 and Sox3 begin to be expressed at preimplantation
and epiblast stages, respectively, and later become restricted
to the neuroepithelium (Collignon et al., 1996; Wood and
Episkopou, 1999). Targeted deletion of Sox2 leads to death
before implantation (Collignon et al., 1996), and chimeric
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abnormalities during gastrulation and posterior truncations
(Parsons, 1997). Sox2 and Sox3 expression may help to
maintain neural progenitor cell identity by inhibiting neuro-
genesis (Bylund et al., 2003; Graham et al., 2003). By
contrast, Sox1 is expressed later in development coincident
with formation of the neural plate (Collignon et al., 1996;
Pevny et al., 1998; Wood and Episkopou, 1999). After neural
induction, Sox1 expression is confined to neural precursors
along the entire anteroposterior axis of the developing
embryo and subsequently to adult neural stem cells. Over-
expression of Sox1 is sufficient to promote neural differen-
tiation of the P19 cell line (Pevny et al., 1998). Moreover, the
brains of Sox1 null mutant mice have a severe loss of
neurons in the ventral striatum including loss of the majority
of the Gad and pre-proenkephalin-expressing neurons in
ventral striatal structures, the olfactory tubercle, and the
nucleus accumbens shell (Malas et al., 2003). Further experi-
ments with ectopic expression of Sox1 in mice and the
analysis of Sox1-null mice harboring Sox1 expressed only
in precursors and not postmitotic neurons indicate that Sox1
is both necessary and sufficient for neuronal differentiation
in the ventral telencephalon (Dr. Vasso Episkopou, MRC,
London, UK, personal communication).
Sox proteins bind sequence-specifically to DNA by a
high-mobility group (HMG) domain that allows them to
function as transcription factors (Sinclair et al., 1990 and
see Wilson and Koopman, 2002). However, unlike most
transcription factors, binding occurs in the minor groove of
DNA resulting in the induction of a bend within the DNA
helix. The HMG domain also appears to be involved in
binding of Sox proteins to other partner proteins including
POU proteins (see Wilson and Koopman, 2002). Such
protein–protein interactions appear to be critical for defin-
ing the specificity of functions of Sox proteins. For
example, Sox2 and Pax6 bind to each other and act
cooperatively to activate transcription from the DC5 en-
hancer of the lens-specific y-crystallin gene (Kamachi et al.,
2001). Similarly, Sox2 and Sox3 interact with Oct3/4 to
regulate gene expression in the pregastrulation embryo
(Nishimoto et al., 1999; Yuan et al., 1995). However, not
all protein–protein interactions involving Sox family mem-
bers involve the HMG domain. For example, the C-termi-
nus mediates interactions of Sox17 with the signaling
molecule h-catenin (Zorn et al., 1999). Interaction of
Sox17 or Sox7 with h-catenin inhibits TCF-mediated
signaling activity thereby interfering with Wnt signaling
(Takash et al., 2001; Zorn et al., 1999). Thus, Sox family
members regulate developmental events not only by acting
as direct transcriptional regulators, but also by forming
protein–protein interactions and acting as either coactiva-
tors or cosuppressors.
This study examines mechanisms by which Sox1 may
regulate neural differentiation and determination. We find
that overexpression of Sox1, but not Sox2 or Sox3, in
neural progenitor cells is sufficient to induce neuronallineage commitment. Sox1 binds to the promoter of
Hes1 thereby suppressing Notch signaling while it sup-
presses h-catenin-mediated TCF/LEF signaling by binding
to h-catenin itself. The C-terminus of Sox1 is required for
both interactions. Overexpression of Sox1 in neural cell
lines activates the expression of the proneural gene neuro-
genin1 and promotes exit from cell cycle and neuronal
differentiation. Thus, Sox1 works through multiple inde-
pendent pathways to promote neuronal cell fate determi-
nation and differentiation.Materials and methods
Plasmids and viruses
A Sox1 full-length expression vector was constructed by
inserting a full-length PCR product into a pLenti6/V5
expression vector using a pLenti6/V5 Directional TOPO
Cloning Kit (Invitrogen). The primers were as follows:
SOX-lenti-5V: CAC CAT GTA CAG CAT GAT GAT
GGA GAC; and SOX-lenti-3V: CTA GAT GTG CGT
CAG GGG CAC.
An IRES-GFP fragment was then inserted into the Sfu
site of this vector, thus creating a Sox1-IRES-GFP expres-
sion vector. A control vector containing GFP alone was then
created by excising Sox1 and religating the vector. Con-
structs with deletion of the C-terminus (DCSox1), deletion
of the N-terminus (DNSox1), or the C-terminus alone (C-
Sox1) were constructed by replacing the full-length Sox1
coding region with the indicated fragments (BamHI + XhoI).
The primers were as follows: C-Sox1: Bam-SOX1c-term5V:
CG GGA TCC AAG ATG GAC AAG TAC TCG CTG G,
Sox1DN3V: CGG CTC GAG CTA GAT GTG CGT CAG
GGG; DNSox1: Sox1DN5V: GGG GAT CCC CCATGA
CCG CCT TCA TGG TG, Sox1DN3V: CGG CTC GAG
CTA GAT GTG CGT CAG GGG; DCSox1: Sox1DC5V:
GGG GAT CCA TGT ACA GCA TGA TGA TGG AG,
Sox1DC3V: CGG CTC GAG CTA CGT CTT GGT CTT
GCG GCG.
An HMG box (flag-tagged) expression vector was con-
structed by inserting the HMG box into a pIRES-hrGFP-1a
vector (Stratagene, inframe with flag), amplifying the HMG
box with flag tag as one fragment and then replacing full-
length Sox1 with this fragment (BamHI + XhoI).
The primers were as follows: 5VHMG-bm: CG GGATCC
AAC ATG GAT CGG GTC AAG CGG CCC; 3VHMG-e: T
CTT GGT CTT GCG GCG CGG CC; and 3VFLAG-x: CCG
CTC GAG TTA TTT GTC GTC ATC ATC CTT.
Lentivirus was made for these vectors using a Virapower
lentiviral support kit (Invitrogen), followed by titration of
viral in 293FT cells.
Hes1 promoter luciferase reporter construct (Hes1-luc)
was generously provided by Prof. Alain. ngn1 and the Hes1-
truncated promoter were amplified from mouse genomic
DNA by PCR and then cloned into a pGL3-Basic vector
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binding site was made by deleting the 6 bp consensus
sequence from the Hes1-luc construct, using a QuikChange
Site-Directed Mutagenesis Kit (Stratagene).
The primers for ngn1 promoter cloning were as follows:
ngn1 pro-kpn1 5V: ACG GTA CCG TCA GTG TTC AGT
TTG ACG GA, and ngn1 pro-BamHI 3V ATG GAT CCC
CGA GTG TGG CAC ACG AC.
The primers for Sox1 promoter cloning were as follows:
Sox1M5V-H: CCC AAG CTT CAT AGC AAG GGA GCA
ACG GCG; and Sox1M3-BMV: GCG GAT CCG GGC GGC
TAG CGG GTT CAC CG.
The primers for cloning of the truncated Hes1 promoter
were as follows: H152: GG GGTACC AGATATATATAG
AGG CCG CCA; and H131: GA AGA TCT GCT TAC
GTC CTT TTA CTT GAC.
The primers for HES1 DS (for deletion of one potential
Sox1 binding site) were as follows: Ds1: CGT GTC TCT
TCC TCC CTG AAA GTTACT GTG; and Ds2: CAC AGT
AAC TTT CAG GGA GGA AGA GAC ACG.
All constructs were confirmed by sequencing and ex-
pression vectors were also confirmed by Western blotting
using anti-tag antibodies or gene-specific antibodies.
Cell culture
Cell lines: 293FT (Invitrogen), HEK293T, P19 and
Neuro-2a (ATCC), and R1 ES cell lines (Nagy et al.,
1993) were used in this study. Cells were maintained in
recommended medium and propagated according to stan-
dard protocols (Graham et al., 1977; Klebe and Ruddle,
1969; McBurney et al., 1982; Nagy et al., 1993).
Neural progenitor cells: Neurosphere cultures were
established as described by Tropepe et al. (1999). Briefly,
telencephalons of embryos (E17) were dissected and me-
chanically dissociated in serum-free neurosphere culture
medium (Vescovi et al., 1993). After 4 days of culture,
primary neurospheres were spun down and dissociated and
were further expanded by transfer into fresh neurosphere
culture medium for generation of secondary spheres. Sec-
ondary spheres were mechanically dissociated and trans-
duced with lentivirus constructs (GFP only and Sox1-IRES-
GFP, respectively) for 2 days, then plated into 24-well
plates containing cover slips coated with PDL and laminin.
The medium was then changed to neurosphere culture
medium without EGF, which was changed every third
day until 7 days after infection when analyses of cell
phenotype were performed. For comparing the effects of
different Sox1B family members on neuronal lineage com-
mitment, E14 neurosphere progenitor cells were electro-
porated with the same amounts (10 Ag) of different DNA
constructs (Sox1-IRES-GFP, Sox2-IRES-GFP, and Sox3-
IRES-GFP), using the Mouse NSE Nucleofector Kit
(Amaxa Inc.) according to the manufacturer’s instructions.
Lineage analyses were performed 7 days later as described
above.Cell cycle and growth curve analysis
HEK293T cells were transduced with 10 multiplicity of
infection (MOI) of lentivirus that expressed HMG-IRES-
GFP, Sox1-IRES-GFP, or GFP, respectively. One day later,
transduced cells were selected with blasticidin (5 Ag/ml).
The cells were selected for six more days (to kill non-
transduced cells) before cell cycle analysis using a Beckman
Coulter Epics XL-MCL followed by the standard PI staining
protocol (Larsen et al., 1986). Since cells overexpressing
Sox1-IRES-GFP cannot survive for prolonged times in
culture, the drug-selected cells were immediately subjected
to cell cycle and growth curve analysis. For growth curve
analysis, the same batch of virally transduced cells were
split and 105 HEK293T cells overexpressing each of the
different constructs were plated into 6-well plates under
normal drug selection. Cell numbers were counted daily for
7 days. Mixed clones were used to do these experiments to
minimize possible effects caused by the sites of integration
of the foreign genes.
Colony formation and rescue assay
In normal liquid medium: Neuro-2A cells were trans-
duced with the indicated expression vectors, and 24 h later
they were split to clonal density in new 10-cm plates. After
another 24 h, blasticidin (5 Ag/ml) was added and the cells
were maintained under selection for 7 days with daily
changes of medium.
In semisolid medium: Neuro-2A cells were transduced
with the indicated expression vectors, and 24 h later the cells
were split to clonal density in new 10-cm plates. After
another 24 h, the medium was changed to a semisolid one
(10 ml 0.8% agarose dissolved in regular medium with
blasticidin, 5 ug/ml). Ten milliliters of regular medium with
blasticidin (5 Ag/ml) was layered on top of this, and the top
medium was changed daily for 7 days.
For rescue experiments: Neuro-2A cells were cotrans-
fected with Dsred-tagged Sox1 (red cells) and GFP-tagged
DN-h-catenin (green cells), and 24 h later the cells were
split to clonal density in new 10-cm plates. After 24 h,
blasticidin (5 Ag/ml) was added and the cells were main-
tained under selection for 7 days with daily changes of
medium.
Luciferase assays
For promoter reporter experiments, HEK293T or P19
cells were cotransfected with 10 ng TK-renilla luciferase
and 0.3 Ag gene-specific promoter reporter constructs
[Hes1-luc (Jarriault et al., 1995) or ngn1-luc] or artificial
reporter constructs (TOPFLASH or FOPFLASH) (kind gifts
of Prof. Hans Clevers) (Korinek et al., 1997) with or without
0.3 Ag indicated expression vectors using FuGENE 6
(Roche). The total amount of DNA was normalized by
adding empty vector. Cells were lysed 36 h later, and
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erase reporter 1000 assay system (Promega) according to the
guide from the manufacturer. All luciferase assays were
performed in duplicate, and normalized relative luciferase
activities were expressed as folds of control activity or ratio
of two different Luciferase activities: Luc/Ren. All assays
were repeated at least three times. Typical results are shown
in the figures.
Chromatin immunoprecipitation (ChIP) assay
Co-immunoprecipitation experiments examining pro-
tein–DNA interactions were performed using the Chroma-
tin Immunoprecipitation (ChIP) Assay Kit (Upstate
Biotechnology). Briefly, P19 cells were split into 10-cm
dishes and 5 Ag of the indicated DNA was transfected into
the cells on the following day. Thirty-six hours later, the
cells were cross-linked by adding formaldehyde directly to
culture medium to a final concentration of 1% and incubat-
ing for 10 min at 37jC (for the ChIP experiment using E10
mouse embryos, the whole embryo was dissected from the
uterus and washed in PBS twice before fixing in the same
final concentration of formaldehyde). The medium was then
removed and the cells were washed twice with ice-cold PBS
containing protease inhibitors (1 mM phenylmethylsulfonyl
fluoride (PMSF), 1 Ag/ml aprotinin, and 1 Ag/ml pepstatin
A). The cells were scraped into a conical tube, pelleted for 4
min at 2000 rpm at 4jC, resuspended in 200 Al of SDS lysis
buffer containing the protease inhibitors, and incubated for
10 min on ice. The lysate was sonicated to shear DNA to
lengths between 200 and 1000 bp and then diluted 10-fold
in ChIP dilution buffer (with protease inhibitors). Two
milliliters of the diluted cell pellet suspension was pre-
cleared with 80 Al of Salmon Sperm DNA/Protein A
Agarose—50% Slurry for 30 min at 4jC with agitation to
reduce nonspecific background. The agarose was pelleted
by brief centrifugation and the supernatant fraction was
collected. The indicated immunoprecipitating antibody
(9E10 antibody for myc-tagged RBP/J and myc-tagged
NICD) was added to 2 ml of the supernatant fraction and
was incubated overnight at 4jC with rotation. Agarose was
then pelleted by gentle centrifugation (700–1000 rpm at
4jC, approximately 1 min), and the supernatant containing
unbound, nonspecific DNA was carefully removed. The
protein A agarose/antibody/protein/DNA was washed for
3–5 min on a rotating platform, and the complex was eluted
from the agarose by adding 250 Al elution buffer to the
pelleted protein A complex, vortexing briefly, and incubat-
ing the mixture at room temperature for 15 min with
rotation. The agarose was carefully pelleted and the super-
natant fraction was carefully transferred to another tube. Ten
microliters of 5 M NaCl was added to the combined eluates
and the protein–DNA cross-links were reversed by heating
at 65jC for 4 h. The eluate was then used as the template for
PCR, and the PCR products were detected on a regular
agarose gel.PCR primers: CTC AGG CGC GCG CCA TTG
GCC, GCT TAC GTC CTT TTA CTT GAC. In vivo
ChIP experiments using E10.5 embryos were done in
same way except that the cross-linking was done at 4jC
for 4 h.
Co-immunoprecipitations
For co-immunoprecipitation experiments, Sox1 (3 Ag)
with or without h-catenin (3 Ag) (gift of B. Vogelstein) as
indicated were cotransfected into HEK293T cells using
calcium phosphate. After 36 h, cells were lysed with IP
buffer (0.5% Triton, 10 mM Tris pH 7.5, 145 mM NaCl,
5 mM EDTA, 2 mM EGTA, with proteinase inhibitors),
and the same amounts of total protein from different
extracts were incubated with an affinity-purified rabbit
anti-SOX1 antibody (gift of Prof. Kondoh) (Kamachi et
al., 1999) directed against the N-terminal peptide
MYSMMMETDLHSPGGA or normal rabbit IgG as indi-
cated at 4jC overnight. UltraLink Immobilized protein G
beads (40 Al, Pierce) were added for 2 h and then the
beads were washed four times with buffer and resus-
pended in 40 Al Laemmli buffer. Western blotting was
performed to probe the blots for specific h-catenin bands
(see following for details). In vivo co-immunoprecipita-
tions using E10.5 embryos were done in a similar way
with normal rabbit-IgG or no antibody pull-downs acting
as negative controls.
Western blot analyses
Western blot analyses were performed according to
standard protocol. Briefly, cell lysates or elutes were re-
solved in 12% PAGE gel. The specific band was detected by
indicated first Abs [rabbit anti-sox1 antibody (gift of Prof.
Kondoh; Kamachi et al., 1999) 1: 2000; rabbit anti-Hes1
(gift of Prof. Tetsuo Sudo; Hirata et al., 2002) 1:500; rabbit
anti-ngn1 (Chemicon) 1:500], followed by desired HRP-
conjugated second Abs, chemiluminescence was detected
by Western Lighting Chemiluminescence Reagent (Perki-
nElmer Life Sciences). Mouse h-actin was used as the
loading control.
Immunohistochemistry
Hes1 immunocytochemistry and hIII-tubulin/GFP dou-
ble staining were performed according to standard proce-
dures. Briefly, cells were fixed in 4% formaldehyde for 10
min at room temperature on the cover slips, then washed
3  5 min, and blocked by 1:10 diluted normal serum for 30
min. The cells were then incubated with the indicated Abs
(1:500 for Hes1 and hIII-tubulin and 1:1000 for chicken
anti-GFP; Chemicon) overnight at 4jC, washed 3  5 min
at room temperature, incubated with the desired second Ab
for 2 h at room temperature, and washed again 3  5 min.
Counter staining for DAPI (1:5000) was performed when
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glass slides.Results
Overexpression of Sox1, but not Sox2 or Sox3, in cultured
neural progenitor cells promotes neuronal lineage
commitment
Overexpression of Sox1 is sufficient to promote neuronal
differentiation in the P19 cell line (Pevny et al., 1998). To
determine whether Sox1 similarly promotes neuronal line-
age commitment by neural stem or progenitor cells, the
effects of overexpression of Sox1 were examined in pro-
genitor cells cultured from E17 telencephalon (Fig. 1).Fig. 1. Overexpression of Sox1, but not Sox2 or Sox3, promotes neuronal lineag
neural progenitor cells were transduced with lentivirus expressing either Sox1-IRE
tubulin. Values represent the meansF SD of the percent of hIII-tubulin+ cells. **D
IRES-GFP-overexpressing cell that is hIII-tubulin+ (I, hIII-tubulin stain; II, GFP s
E14 progenitor cells were electroporated with the same amounts of different DNA
GFP. Seven days later, the cells were examined for expression of hIII-tubulin. Val
from control (GFP negative cells) by ANOVA at P < 0.05.Lentiviral vectors were used to transduce Sox1-IRES-GFP
or GFP alone into mechanically dissociated E17 neuro-
sphere progenitor cells. Approximately 20% of control
(nontransduced) progenitor cells differentiated into hIII-
tubulin immunoreactive cells. Similarly, only about 20%
of cells transduced with GFP alone differentiated into hIII-
tubulin positive cells. By contrast, between 70% and 80% of
cells overexpressing Sox1 differentiated into hIII-tubulin+
cells (Fig. 1A) that adopted a neuronlike morphology (Fig.
1B). This suggests that Sox1 alone is sufficient to promote
neuronal differentiation of neural stem or progenitor cells.
To compare the effects of different Sox1B family members,
that is, Sox1, Sox2, and Sox3, on neuronal lineage com-
mitment, we electroporated the same amounts of DNA of
Sox1-IRES-GFP, Sox2-IRES-GFP, or Sox3-IRES-GFP con-
structs into cultured E14 progenitor cells (Fig. 1C). Ap-e commitment by cultured telencephalic progenitor cells. (A) Cultured E17
S-GFP or GFP alone and were examined 7 days later for expression of hIII-
iffers from all other groups by ANOVA at P < 0.01. (B) Example of a Sox-
tain; and III, merge). Note the typically neuronal morphology. (C) Cultured
constructs including Sox1-IRES-GFP, Sox2-IRES-GFP, Sox3-IRES-GFP, or
ues represent the means + SD of the percent of hIII-tubulin+ cells. *Differs
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itor cells differentiated into hIII-tubulin immunoreactive
cells in each group. By contrast, a significantly increased
number (approximately 60%) of cells overexpressing Sox1
differentiated into hIII-tubulin+ cells, whereas a significant-
ly reduced number (approximately 15%) of cells overex-
pressing Sox2 differentiated into hIII-tubulin+ cells. About
28% of cells overexpressing Sox3 differentiated into hIII-
tubulin+ cells, which did not differ from the GFP negative
group. These results indicate that Sox1 promotes neuronal
lineage commitment by cultured progenitor cells whereas
Sox2 conversely inhibited cells from committing to the
neuronal lineage. Sox3 had no significant effect on lineage
commitment by neural progenitor cells in this assay.Fig. 2. Sox1 suppresses Hes1 transcription through direct binding to the Hes1 pro
that Sox1 suppresses Hes1 promoter activity in a dose-dependent way in HEK293T
0, 30, or 120 ng of Sox1 expression vector with or without 30 ng of the NICD expr
control by ANOVA at P < 0.01. (B) Sox1 suppresses Hes1 transcription through
the wild-type Hes1 promoter with a mutant full-length promoter lacking the potent
site and upstream sequence. Note that the promoter without the putative Sox bind
promoter without both RBP/J and the Sox binding site does not respond to either
ANOVA at P < 0.01. (C) ChIP assay demonstrates that Sox1 binds directly to the
used as positive controls, while cells without any treatment and cells transfected w
only in cells that overexpressed Sox1, NICD, or RBP/J and were not detected in the
band only in the Sox1 antibody lane and not in the control lanes. (E) Truncated a
play key roles in the suppression of the Hes1 promoter, four truncated SOX1 expres
GFP (Sox1 without the N-terminus), DCSox1-IRES-GFP (Sox1 without the C-ter
full-length sox1 with indicated PCR fragments in pLenti6/V5 expression vector.
blotting (not shown). (F) Intact Sox1 is needed to suppress the Hes1 promoter. P19
reporter gene. Note that DNSox1-IRES-GFP can suppress Hes1 promoter activity
GFP constructs cannot suppress the Hes1 promoter. **Differs from NICD-overexpr
in duplicate and were repeated at least three times.Sox1 binds directly to the Hes1 promoter in cells and
suppresses Hes1 transcription
The mechanisms by which Sox1 promotes neuronal
lineage commitment are unknown. Sox family proteins
have been shown to function as cosuppressors as well as
coactivators depending upon the cellular context (see
Wilson and Koopman, 2002). Therefore, one possible
mechanism for the proneural effects of Sox1 is suppres-
sion of the helix-loop-helix transcription factor Hes1,
which is expressed downstream of Notch signaling and
which is a potent inhibitor of neurogenesis. To test this
hypothesis, we first examined the effects of overexpression
of Sox1 on the activities of the Hes1 promoter in P19 andmoter. (A) Luciferase reporter assays using the Hes1 promoter demonstrate
(shown here) and P19 (not shown) cell lines. Cells were cotransfected with
ession vector. *Differs from control by ANOVA at P < 0.05; **differs from
the putative Sox binding site. Luciferase assays were performed comparing
ial Sox protein binding site and a truncated form without the RBP/J binding
ing site does not respond to Sox1 but responds well to NICD, whereas the
. *Differs from control by ANOVA at P < 0.05; **differs from control by
Hes1 promoter. P19 cells overexpressing myc-tagged NICD and RBP/J were
ith empty vector served as negative controls. Specific bands were detected
negative controls. (D) ChIP assays using E10.5 embryos detected a specific
nd full-length expression vectors of Sox1 proteins. To map which domains
sion vectors were constructed—HMG box-IRES-GFP only, DNSox1-IRES-
minus), andC-Sox1-IRES-GFP (C-terminal portion of Sox1)—by replacing
Protein expression and stability of the vectors was confirmed by Western
cells were cotransfected the indicated constructs with the Hes1 the promoter
whereas the HMG box-IRES-GFP, DCSox1-IRES-GFP, and C-Sox1-IRES-
essing lane by ANOVA at P < 0.01. All luciferase assays were done at least
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a well-established Hes1 promoter reporter gene construct,
Hes1-luc (Jarriault et al., 1995). We found that over-
expression of Sox1 suppresses Hes1 promoter activity in
a dose-dependent fashion with as much as a 70% reduc-
tion in both cell lines (Fig. 2A). We then transfected the
reporter cells with Sox1 alone or along with a Hes
activator [the constitutively active Notch intracellular do-
main, (NICD)] and found that Sox1 suppressed Hes1
promoter activity to a similar extent even in the presence
of constitutively active Notch signaling (Fig. 2A). Analysis
of the sequence of the mouse Hes1 promoter revealed one
ATTGGC sequence, a potential consensus Sox binding
sequence (Harley et al., 1994; Wiebe et al., 2000; 2003),
located just 8 bp upstream of the RBP/J binding site. To
determine whether this is the cis-element that actually
responds to Sox1, we made a mutant promoter reporter
construct that lacks only the putative Sox binding site and
a second truncated construct that lacks the RBP/J and Sox
binding sites as well as the sequence 5V to these sites.
Luciferase assays in both cell lines indicated that theFig. 3. Sox1 suppresses endogenous expression of Hes1. Neuro-2A cells were t
construct and were examined immunohistochemically after 2 days for Hes1 and GF
overexpressed Sox1-IRES-GFP, both in cytoplasm and nucleus (I, II, and III, w
expression was virtually unchanged in cells that overexpressed GFP only (IV, V,promoter lacking the putative Sox site failed to respond
to Sox1 but did respond to NICD while the truncated
promoter construct failed to respond to either Sox1 or
NICD (Fig. 2B). These observations suggest that this
putative Sox binding site is responsible for the Sox1-
mediated suppression of Hes1 expression. To further
confirm this finding, we utilized a chromatin immunopre-
cipitation assay (ChIP assay), which can detect in vivo
physical interactions between identified proteins and spe-
cific portions of cellular DNA, to examine protein inter-
actions with the Hes1 promoter. P19 cells were transfected
with Sox1, myc-tagged NICD or RBP/J (positive controls),
or empty vector (pcDNA3) (negative control), and untrans-
fected cells served as an additional negative control (Fig.
2C). The proteins were immunoprecipitated and analyzed
for co-immunoprecipitation of the Hes1 promoter region.
Sox1, NICD and RBP/J each interacted specifically with
the Hes1 promoter thus giving a specific band in the ChIP
assay whereas no bands were detected in any of the
negative controls. Further, a ChIP assay using the same
antibodies with tissue from E10.5 mouse embryos alsoransfected with Sox1-IRES-GFP, GFP alone, or the HMG box-IRES-GFP
P expression. Hes1 expression was dramatically down-regulated in cells that
hite arrows indicate Sox1-IRES-GFP-overexpressing cells), whereas Hes1
and VI) or HMG-IRES-GFP (VII, VIII, and IX).
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2D). These findings demonstrate that Sox1 interacts di-
rectly with the Hes1 promoter in cells.
We next sought to define the domain of Sox1 that is
responsible for the suppression of Hes1 expression. To
address this issue, we used a luciferase reporter assay to
examine the function of four truncated Sox1 expression
vectors together with a full-length Sox1 expression vector
(Fig. 2E): HMG-IRES-GFP only (flag tagged), DNSox1-
IRES-GFP (Sox1 without the N-terminus), DCSox1-IRES-
GFP (Sox1 without the C-terminus), and C-Sox1-IRES-GFP
(C-terminal region only). All of the expression vectors
expressed specific proteins at similar levels and apparent
stability since Western blotting detected similar levels of
specific bands after different time points of transient expres-
sion (data not shown). Loss of the C-terminus but not loss of
the N-terminus significantly impaired the ability of Sox1 toFig. 4. Sox1 binds to h-catenin and suppresses h-catenin-mediated TCF/LEF s
interacts with h-catenin. HEK293T cells were transfected with empty vector, Sox1
immunoglobulin (Ig) or with Sox1 antibody (aSox1). Eluates were resolved on a
specific h-catenin band was detected only in cells that overexpressed Sox1 (with or
were immunoprecipitated with Sox1 antibody, normal rabbit-IgG, or no antibody
mouse anti-h-catenin antibody. A specific h-catenin band was detected in the So
Sox1 suppresses h-catenin-mediated TCF/LEF signaling. HEK293T cells were
TOPFLASH reporter gene and dual-luciferase activities were measured as describ
TCF/LEF signaling with efficiency comparable to full-length Sox1, whereas HMG
**Sox1 lane differs from control at P < 0.01 h-cat + Sox1, and h-cat + Dnsox diff
least in duplicate and were repeated three times. Typical results are shown in theinhibit the Hes1 promoter. However, neither the C-terminus
alone nor the HMG box alone was able to suppress the Hes1
promoter. Finally, we examined whether Sox1 suppresses
endogenous Hes1 expression in neural lineage cells using
Neuro-2A cells, a neural progenitor cell line that expresses
moderately high endogenous levels of both Hes1 and ngn1.
Cells were transfected with Sox1-IRES-GFP, GFP alone, or
the HMG-IRES-GFP and were examined immunocytochem-
ically for expression of Hes1 and of the transgenes using a
well-characterized anti-Hes1 antibody (Hirata et al., 2002).
This antibody gives a major specific band of about 35KD in
Western blotting (Hirata et al., 2002, and data not shown)
and specifically immunostains Hes1 in both the cytoplasm
and the nucleus (Kabos et al., 2002). Untransfected cells and
cells tranfected with either GFP or the HMG-IRES-GFP
virtually all expressed Hes1 (Fig. 3). By contrast, more than
80% of cells transfected with Sox1-IRES-GFP were devoidignaling. (A) Co-immunoprecipitation demonstrates that Sox1 specifically
, or h-catenin as indicated and were immunoprecipitated with either control
12% PAGE gel and were probed with a mouse anti-h-catenin antibody. A
without h-catenin co-overexpression). (B) Cell lysates from E10.5 embryos
lanes. Eluates were resolved on a 12% PAGE gel and were probed with a
x1 lane but not in either control lane. (C) TOPFLASH assay indicates that
transfected with truncated or full-length Sox1 with h-catenin, and the
ed above. Note that DNSox1-IRES-GFP can suppress h-catenin-mediated
-IRES-GFP, DCSox1-IRES-GFP, and C-Sox1-IRES-GFP cannot suppress it.
er from h-cat lanes by ANOVA at P < 0.01. Luciferase assays were done at
figures.
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arrows in Figs. 3I and II indicate the typical Sox1-IRES-GFP
positive cells) whereas neighboring untransfected cells all
displayed Hes1 immunoreactivity. These observations indi-
cate that Sox1 expression suppresses endogenous levels of
Hes1 in neuro2A cells. Collectively, these observations
indicate that Sox1 binds directly to the Hes1 promoter and
down-regulates Hes1 expression, thereby freeing neural
progenitor cells from the inhibitory effects of Hes1 on
neuronal lineage commitment.Fig. 5. Neuro-2A cells that overexpress Sox1 do not form colonies and undergo n
transfection with the indicated expression vectors, Neuro-2A cells were split to
medium and the medium with blasticidin was changed daily. Fluorescent image
selection. Fluorescent images from 1 day after transfection (I, II, and III) demons
different constructs. Fluorescent images taken 7 days after drug selection (IV, V,
IRES-GFP (IV) formed well-defined colonies whereas cells that overexpressed
GFP/hIII-tubulin double staining of mature neuron-like cells from a plate of cel
merge). (C) h-catenin signaling could not reverse the effects of Sox1 on cell prol
GFP, or both. Fluorescent images from 1 day after transfection (I, II, and
overexpressing the different constructs. Three types of fluorescent cells were ob
cells transfected with GFP-tagged DN-h-catenin (green cells), and cells transfec
cells). Fluorescent images taken 7 days after drug selection (IV, V, and VI) dem
defined colonies whereas red cells (Sox1-IRES-GFP positive) or yellow cells (S
colonies. See Table 1.SOX1 binds to b-catenin and suppresses
b-catenin-mediated TCF/LEF signaling
The foregoing observations indicated that at least some
of the proneural effects of Sox1 may result from suppres-
sion of the inhibitory actions of Hes1. We next sought to
determine whether Sox1 also regulates neurogenesis
through other mechanisms. Two prior studies suggested
that other Sox family members may regulate the function
of h-catenin (Takash et al., 2001; Zorn et al., 1999), aneuronal differentiation instead. (A) Colony formation assay: One day after
clonal density. The following day, blasticidin (5 ug/ml) was added to the
s (low power) were taken 1 day after transfection and 7 days after drug
trate that transfection efficiencies were similar for cells overexpressing the
and VI) demonstrate that cells that overexpressed GFP only (VI) or HMG-
Sox1-IRES-GFP survived but did not form colonies (V). (B) Example of
ls overexpressing Sox1-IRES-GFP (I: GFP stain; II: hIII-tubulin; and III:
iferation. Cells were transfected with Sox1-IRES-Dsred, DN-h-CAT-IRES-
III) demonstrate that transfection efficiencies were similar for cells
served in the plates: cells transfected with Dsred-tagged Sox1 (red cells),
ted with both Dsred-tagged Sox1 and GFP-tagged DN-h-catenin (yellow
onstrate that only green cells (DN-h-catenin-GFP positive) formed well-
ox1-IRES-GFP + DN-h-catenin-GFP positive) survived but did not form
Table 1
Clonogenic activities of different constructs after 7 days of selection (total
clones from 20 random low-power fields)
Sox1-
IRESdsRed
h-CAT-
IRES-GFP
Sox1-IRES-dsRed +
h-CAT-IRES-GFP
Red clones
(dsRed)
0 0 0
Yellow clones
(dsRed + GFP)
0 0 0
Green clones
(GFP)
0 55 47
Quantification of the clonogenic activities of the different constructs
showed in Fig. 5C. Clusters of cells containing at least five cells were
counted from 20 total random low power (5) fields. Only cells
overexpressing DN-h-CAT-IRES-GFP were able to form well-defined
clones (green clones). Neither cells overexpressing Sox1-IRES-DsRed (red
cells) nor cells overexpressing Sox1-IRES-DsRed + DN-h-CAT-IRES-GFP
(yellow cells) formed well-defined clones.
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system (see Patapoutian and Richard, 2000). Therefore,
to determine whether Sox1 binds to h-catenin expressed in
the same cells, lysates of HEK293T cells were immuno-
precipitated with an anti-Sox1 antibody and the precipitates
were probed by Western analysis with an anti-h-catenin
antibody. Since HEK293T cells endogenously express low
levels of h-catenin but not Sox1 (data not shown), no band
was observed in control cells (Fig. 4). Further, even after
transfection of the cells with h-catenin no band was
detected in the absence of Sox1. However, after transfec-
tion of the cells with Sox1, h-catenin was coprecipitated by
the Sox1 antibody (Fig. 4A, lane 2). Moreover, over-
expression of h-catenin along with Sox1 greatly enhanced
the amount of h-catenin that was co-immunoprecipitated
by the Sox1 antibody (Fig. 4A, lane 8), suggesting that
Sox1 can bind to h-catenin in vivo. Importantly, using
protein lyses from E10.5 mouse embryos, which express
both Sox1 and h-catenin, a specific band h-catenin was
immunoprecipitated by the Sox1 antibody but not by an
irrelevant antibody or in the absence of antibody (Fig. 4B).
The effects of this interaction on h-catenin-mediated TCF/
LEF signaling were therefore examined using the TOP-
FLASH reporter assay (Fig. 4C), a well-characterized in
vitro system for testing h-catenin-mediated TCF/LEF sig-
naling (Korinek et al., 1997). Expression of h-catenin
significantly increased TCF/LEF reporter activity as
expected. However, expression of Sox1-IRES-GFP sup-
pressed TCF/LEF reporter activity, and coexpression of
Sox1-IRES-GFP and h-catenin not only blocked the stim-
ulatory effects of h-catenin but also significantly reduced
activity below control levels, presumably by inhibiting the
effects of endogenous h-catenin. Coexpression of the
HMG-IRES-GFP along with h-catenin had little effect.
However, coexpression of DNSox1-IRES-GFP (Sox1 with-
out the N-terminus) along with h-catenin exerted inhibitory
effects equivalent to those of full-length Sox1. By contrast,
coexpression of DCSox1-IRES-GFP (Sox1 without the C-
terminus) did not alter the effects of h-catenin, indicating
that the C-terminus is necessary for Sox1 to suppress h-
catenin-mediated TCF/LEF signaling. Nevertheless coex-
pression of the C-terminal region alone (C-Sox-IRES-GFP)
did not inhibit the effects of h-catenin, indicating that the
C-terminus of Sox1 is necessary but not sufficient to
suppress h-catenin-mediated TCF/LEF signaling. Coex-
pression of greatly elevated amounts of h-catenin (4:1
and 8:1) with Sox1 in the TOPFLASH assay partly
reversed the Sox1-mediated inhibition of the TOPFLASH
reporter (data not shown).
Overexpression of Sox1 inhibits cell proliferation and
promotes neuronal differentiation, and the changes are
not rescued by B-catenin
h-catenin-mediated TCF/LEF signaling is typically a
strong stimulus for cell proliferation. Since Sox1 binds toh-catenin and inhibits TCF/LEF signaling, we sought to
determine whether Sox1 expression influences cell cycle.
Neuro-2A cells were transfected with Sox1-IRES-GFP, GFP
alone, or the HMG-IRES-GFP construct and plated at clonal
density, and colony formation assays were performed. At 1
day after transfection, there were no major differences in
terms of transfection efficiency or morphology among cells
transfected with the different constructs (Figs. 5A, I–III).
Note that most GFP-expressing cells were doublets at this
time, probably due to one round of division. The cells were
then subjected to drug selection so that cells without any
constructs would not survive. Daily observations thereafter
revealed that cells transfected with Sox1-IRES-GFP ceased
proliferating and survived mostly as doublets or singlets,
whereas cell transfected with GFP alone or with HMG-
IRES-GFP kept proliferating (data not shown). Seven days
after selection, the cells transfected with GFP alone or with
the HMG-IRES-GFP formed well-defined colonies (or
clusters), whereas cells transfected with Sox1 survived as
doublets or singlets but did not form colonies (Figs. 5A,
IV–VI). More than 90% of the Sox1-IRES-GFP-transfected
cells expressed hIII-tubulin, whereas less than 1% of control
cells overexpressing GFP alone or HMG-IRES-GFP
expressed hIII-tubulin (data not shown). Further, about
10% of the Sox1-IRES-GFP-transfected cells extended long
processes and adopted a neuronlike morphology (Figs. 5B,
I–III), whereas only rare such cells were detected in the
GFP alone or HMG-IRES-GFP groups. The number of
GFP+ cells in the Sox1-IRES-GFP group remained virtually
unchanged during the 7 days of selection, whereas GFP+
cell numbers in control groups increased significantly (data
not shown), consistent with the lack of proliferation of
Sox1-IRES-GFP-transfected cells demonstrated by the col-
ony forming assay. However, it remained possible that the
differences in GFP+ cell numbers represented differences in
cell adhesion among the groups of cells, that is, Sox1-IRES-
GFP cells could have proliferated but were detached from
the plates for some reason and were washed away during
medium changes. To test this possibility, a semisolid medi-
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were confined to a small area and could not detach and/or be
washed away. Similar results were obtained supporting the
conclusion that Sox1 promotes exit from cell cycle and
cellular differentiation (data not shown). The fact that GFP+
cell numbers in the Sox1-IRES-GFP group remained virtu-
ally unchanged and did not decrease significantly during the
7-day selection period argues against the possibility of cell
death as the cause of the differences in GFP+ cell numbers
among groups.
To determine whether h-catenin signaling could reverse
the effects of Sox1 on cell proliferation, Neuro-2A cellsFig. 6. Constitutive overexpression of Sox1 in HEK293T cells promotes exit from
with HMG-IRES-GFP, GFP only, or Sox1-IRES-GFP for 1 day (I, II, and II
morphologies. Cells overexpressing HMG-IRES-GFP (IV) had a similar cell cyc
overexpressing Sox1-IRES-GFP (VI) had a marked reduction in the number of
analysis of the cell cycle distributions in A. (C) Growth curve analysis supports the
effect. Cells overexpressing GFP (blue line) proliferated normally (cell numbers do
proliferated but at a reduced rate. By contrast, the number of cells overexpressi
*Differs from cells overexpressing Sox1-IRES-GFP by ANOVA at P < 0.05; **d
(D) Overexpression of Sox1 for prolonged times leads to morphological changes
than 4 days became larger and rounder, and some cells show signs of apoptosis. U
(phase, GFP, and merge, respectively), while the lower panel shows the typical mor
(phase, GFP, and merge, respectively).were cotransfected with Dsred-tagged Sox1 and GFP-tagged
DN-h-catenin. One day after transfection, four types of cells
were observed in the plates: cells transfected with Dsred-
tagged Sox1 (red cells), cells transfected with GFP-tagged
DN-h-catenin (green cells), cells transfected with both
Dsred-tagged Sox1 and GFP-tagged DN-h-catenin (yellow
cells), and cells without any of these constructs (negative).
Daily observations thereafter found that red and yellow cells
stopped proliferating while green cells kept proliferating.
Seven days later, only the green cells formed well-defined
clones (Fig. 5C and Table 1). Thus, enhanced h-catenin
signaling was unable to overcome the effects of Sox1 on cellcell cycle. (A) Over 80% of the cells were GFP positive after transduction
I). Note that cells overexpressing different constructs have very similar
le profile to the cells overexpressing GFP only (V). By contrast, the cells
cells in G2 and an increase in apparently apoptotic cells. (B) Quantitative
hypothesis that constitutive overexpression of Sox1 has an antiproliferative
ubled daily), while cells overexpressing HMG-IRES-GFP (yellow line) also
ng Sox1-IRES-GFP (red line) remained virtually unchanged over 7 days.
iffers from cells overexpressing Sox1-IRES-GFP by ANOVA at P < 0.01.
. HEK293T cells that constitutively overexpress Sox1-IRES-GFP for more
pper panel shows the typical morphology of long-term overexpressing cells
phology of HEK293T cells overexpressing GFP only in the same time point
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diated TCF/LEF signaling may not be the only way that
Sox1 regulates cell cycle.
Sox1 promotes exit from cell cycle
To confirm and further define the effects of Sox1 on
cell cycle, a different cell line, HEK293T cells, was used
to create cell lines overexpressing Sox1-IRES-GFP, GFP
alone, or the HMG-IRES-GFP construct. The advantage
of using this cell line is that we were able to have
cultures with more than 80% positive cells, thus mini-
mizing the effects of nontransduced cells on the cell cycle
analysis. Since the Sox1-IRES-GFP-overexpressing cells
could not survive in the long term, we transduced the
cells and drug selected them for 7 days, and the selected
cells were then immediately subjected to cell cycle
analysis using an automated flow cytometer (Fig. 6).
The cell cycle profiles of cells overexpressing GFP alone
or the HMG-IRES-GFP were similar (Fig 6A). By con-
trast, the profile of cells overexpressing Sox1-IRES-GFP
was significantly different with a small increase in the
percentage of cells in G1 and a very large decrease in theFig. 7. Sox1 activates expression of neurogenin1. (A) Luciferase reporter assays
promoter activity in a dose-dependent way. P19 cells were transfected with dif
luciferase activities were measured as described above. **Differs from control b
expression. Northern blot analysis of total RNA extracted from Neuro-2A cell
endogenous ngn1 mRNA expression is up-regulated in the Sox1 overexpressing ce
the relative amount of ngn1 mRNA. **Differs from control by Student’s t test at
analysis of endogenous ngn1 protein expression in Neuro-2A cells transiently
demonstrates that Sox1 up-regulates levels of endogenous ngn1 protein. h-actin se
of ngn1 protein. *Differs from control by ANOVA at P < 0.05. (F) Working mode
unknown, or indirect effects as dashed lines. See text for detailed descriptions.percentage of cells in G2 (Figs. 6A and B). This indicates
that cells overexpressing Sox1-IRES-GFP remained in G1
and were blocked from entering the G2 phase. There was
also an increase in apoptosis of cells overexpressing
Sox1-IRES-GFP, whereas no apoptotic cells were detected
in the GFP-alone or the HMG-IRES-GFP groups (Figs.
6A and B).
Growth curve analyses were then performed with the
same cells (Fig. 6C). The GFP-overexpressing cells prolif-
erated normally whereas the Sox1-IRES-GFP-overexpress-
ing cells did not proliferate at all and cell numbers actually
decreased, though not significantly, after 4 days in culture,
consistent with the previous cell cycle analysis. The cells
that overexpressed the HMG-IRES-GFP proliferated but at a
slower rate than the control. This may indicate that over-
expression of the HMG box alone has some subtle effects,
which the cell cycle analysis was not sensitive enough to
detect. Morphologic analysis of the cell lines indicated that
the Sox1-IRES-GFP-overexpressing cells enlarged in size
and became more ovoid with time in culture, but significant
morphologic changes were detectable only after 3–4 days in
culture, indicating that this may reflect an indirect secondary
effect (Fig. 6D). There were also some cells that appeared tousing the neurogenin1 promoter demonstrated that Sox1 up-regulates ngn1
ferent dosages of Sox1 along with the ngn1 promoter reporter, and dual-
y ANOVA at P < 0.01. (B) Sox1 up-regulates endogenous ngn1 mRNA
s transiently overexpressing GFP only or Sox1-IRES-GFP indicates that
lls. The lower panel is an RNA loading control. (C) Quantitative analysis of
P < 0.01. (D) Sox1 up-regulates endogenous ngn1 protein. Western blot
overexpressing GFP, Sox1-IRES-GFP, or HMG-IRES-GFP, respectively,
rved as the loading control. (E) Quantitative analysis of the relative amount
l of Sox1 functions on neurogenesis. Direct effects are shown as solid lines,
L. Kan et al. / Developmental Biology 269 (2004) 580–594592be undergoing apoptosis, consistent with the cell cycle
analysis.
Sox1 activates transcription of the proneural gene
neurogenin1
Although Sox1 expression inhibited h-catenin-mediated
TCF/LEF signaling and Sox1 and h-catenin also appear to
exert opposing effects on cell proliferation, both reportedly
exert proneural effects (Israsena et al., in press; Patapoutian
and Richard, 2000; Pevny et al., 1998). The ability of Sox1
to drive the promoter of the proneural transcription factor
neurogenin1 (ngn1) was therefore examined using a lucif-
erase reporter assay. The ngn1-luc construct used in this
experiment contained about 1.6 kb genomic DNA from the
predicted mouse ngn1 promoter region (Israsena et al., in
press). Expression of Sox1 up-regulated ngn1 promoter
activity in a dose-dependent manner (Fig. 7A). To determine
whether Sox1 actually promotes expression of endogenous
ngn1 in neural-derived cells, Neuro-2a cells were trans-
fected with Sox1-IRES-GFP, GFP, or the HMG-IRES-GFP,
and the cells were examined for levels of ngn1 mRNA
(Figs. 7B and C) and protein (Figs. 7D and E) 1 day later.
Overexpression of Sox1-IRES-GFP significantly increased
levels of ngn1 mRNA about 16-fold and more than doubled
levels of ngn1 protein, consistent with the proneural effects
of Sox1. Thus, the findings with the luciferase reporter that
Sox1 activates transcription of ngn1 were substantiated by
both Northern (Figs. 7B and C) and Western blotting (Figs.
7D and E).Discussion
Our current studies provide evidence that Sox1 may
regulate neurogenesis through several different mechanisms
(Fig. 7F). Once activated, Sox1 (1) binds directly to the
Hes1 promoter and suppresses Hes1 transcription, thus
attenuating Notch signaling; (2) binds to h-catenin and
suppresses h-catenin-mediated TCF/LEF signaling, thus
potentially attenuating the wnt signaling pathway; (3) pro-
motes exit of cells from cell cycle; and (4) up-regulates
transcription of the proneural bHLH transcription factor
neurogenin1. The net effects of Sox1 signaling are neuronal
lineage commitment and exit of the cell from cell cycle.
Sox1 is abundantly expressed in vivo by ventricular zone
progenitor cells during the period of neurogenesis, and the
temporal and spatial patterns of expression overlap with
Notch and Wnt (h-catenin) expression. This suggests that
Sox1 is normally involved in neurogenesis in vivo. This
conclusion is supported by the observation that Sox1 null
mutant mice exhibit a severe loss of neurons in ventral
striatal structures, the olfactory tubercle and the nucleus
accumbens shell, and that adult mice suffer from spontane-
ous seizures. (Malas et al., 2003). Further experiments with
ectopic expression of Sox1 in mice and the analysis ofSox1-null mice harboring Sox1 expressed only in precursors
and not postmitotic neurons indicate that Sox1 is both
necessary and sufficient for neuronal differentiation in the
ventral telencephalon (Dr. Vasso Episkopou, personal com-
munication). Our results are also consistent with observa-
tions that overexpression of Sox1 is sufficient to promote
neural differentiation of the P19 cell line (Pevny et al.,
1998). However, we found that other SoxB1 family mem-
bers (Sox2 and Sox3) that are expressed in the developing
nervous system do not promote neurogenesis and that Sox2
actually inhibited neuronal lineage commitment. These
findings are consistent with recent reports indicating that
Sox2 and Sox3 expression may help to maintain neural
progenitor cell identity by inhibiting neurogenesis (Bylund
et al., 2003; Graham et al., 2003). We do not agree,
however, with the extension to Sox1 in one of these reports
(Bylund et al., 2003) of their experimental findings with
Sox2 and Sox3. The apparent inconsistencies between
Bylund et al. (2003) and our findings could be explained
in several ways. First, Bylund et al. (2003) never actually
presented the data of Sox1 functional analysis, and the
extension of their findings with Sox2 and Sox3 to Sox1
may be unwarranted. Our observations that these factors
may have divergent effects on neuronal lineage commitment
(Fig. 1) suggest that each member of the SoxB1 family may
have specific nonredundant functions in the developing
CNS. This conclusion is consistent with the different but
overlapping temporal and spatial patterns of expression of
the different Sox1B family members and it is also consistent
with the different phenotypes of null mutant mice (Avilion
et al., 2003; Collignon et al., 1996; Nishiguchi et al., 1998;
Parsons, 1997). Sox2 and Sox3 begin to be expressed at
preimplantation and epiblast stages, respectively, and later
become restricted to the neuroepithelium (Collignon et al.,
1996; Wood and Episkopou, 1999). Targeted deletion of
Sox2 leads to death before implantation (Collignon et al.,
1996), and chimeric mice generated with Sox3 null ES cells
display severe abnormalities during gastrulation and poste-
rior truncations (Parsons, 1997). By contrast, Sox1 is
expressed later in development coincident with formation
of the neural plate (Collignon et al., 1996; Pevny et al.,
1998; Wood and Episkopou, 1999). After neural induction,
Sox1 expression is confined to neural precursors along the
entire anteroposterior axis of the developing embryo and
subsequently to adult neural stem cells.
Sox family proteins have been shown to function as
cosuppressors as well as coactivators depending upon the
cellular context (see Wilson and Koopman, 2002). Thus, the
effects of Sox1 may be context dependent, and the discrep-
ancies between our findings and those of Bylund et al.
(2003) could also reflect differences in the ways that Sox
function was examined. However, the observation in Sox1
mutant mice that Sox1 is both necessary and sufficient for
neuron differentiation in the ventral telencephalon suggests
that our observations reflect the function normally served by
Sox1 in vivo.
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differ from the findings of Buescher et al. (2002) for the
putative SoxB1 homologues in Drosophila, Dichaete, and
SoxNeuro, which reportedly do not antagonize Notch sig-
naling. This suggests either that Dichaete and SoxNeuro are
not precise homologues of the SoxB1 family or that the
murine proteins act through different mechanisms. Muta-
tions of Drosophila SoxNeuro lead to defects in the spec-
ification and differentiation of midline and lateral neural
cells, and SoxNeuro or Dichaete double mutants have
severe hypoplasia of the entire central nervous system
(Buescher et al., 2002; Overton et al., 2002). Regardless
of the reasons for the species differences, the presence of the
consensus Sox binding site on the mouse Hes1 promoter,
the direct demonstration that Sox1 binds to the Hes1
promoter, and the inhibition of Notch signaling in cells that
overexpress Sox1 strongly support the biologic importance
of this regulatory mechanism.
Our findings regarding interactions of Sox1 with h-
catenin are consistent with prior observations that Sox17
physically interacts with h-catenin (Zorn et al., 1999) and
that Sox7 as well as Sox17 inhibits wnt signaling (Takash et
al., 2001). The interaction of Sox1 with h-catenin depends
upon the C-terminus rather than the HMG box, indicating
that different domains of the Sox1 molecule may mediate
different regulatory functions during mouse development.
h-catenin is a potent signal for maintaining neural progen-
itor cells in a proliferative state (Chen and Walsh, 2002), and
interactions between the Sox proteins and h-catenin may be
important for maintaining a balance between proliferation
and differentiation of neural progenitor cells. Our conclu-
sions regarding the effects of Sox1 on cell proliferation
differ somewhat from the conclusions of Pevny et al.
(1998). We both find that Sox1 is a potent neurogenic factor
that is expressed by dividing progenitor cells and that Sox1
expression is down-regulated concurrent to exit from cell
cycle and commitment to the neuronal lineage. However,
our findings suggest that Sox1 expression may be part of an
in vivo feedback mechanism for the control of cell number
in the CNS, that is, that Sox1 up-regulation is the result of
proliferation of neural progenitors rather than the cause. Our
finding that Sox1-transfected cells appear to undergo one
additional round of division before exiting cell cycle and
committing to the neuronal phenotype would be consistent
with such a role. Moreover, although Sox1 is down-regu-
lated in most postmitotic neurons, it is still found in ventral
striatal structures, the olfactory tubercle, and the nucleus
accumbens shell (Malas et al., 2003). Sox1 is also expressed
in scattered neurons in other adult brain regions (unpub-
lished observations).
In addition to the effects of Sox1 in blocking the
inhibitory effects of Notch signaling, Sox1 promotes ex-
pression of the proneural gene neurogenin1. Although the
neurogenin1 promoter has a Sox consensus binding site, it is
not clear that there is a direct effect of Sox1 on the neuro-
genin gene. Chromatin precipitation assays failed to identifya direct interaction between Sox1 and the ngn1 promoter,
and gel shift assays using the potential Sox1 binding site in
the promoter region of ngn1 also failed to demonstrate an
interaction (data not shown). This suggests that Sox1 could
regulate ngn1 promoter activity through indirect mecha-
nisms. Regardless of whether the effects on neurogenin1 are
direct or indirect, it is apparent that Sox1 expression may
promote neuronal lineage commitment through multiple
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